Search research articles
Contact Us
Filters
Showing results (51-60 of 120) with videos related to
Page
of 12
Sort By:
Neuro-Oncology Advances
|
June 7, 2024
Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomas
Colin M Harari, Adam R Burr, Brett A Morris, et al.
Molecular Imaging and Biology
|
June 12, 2019
[<sup>124</sup>I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors
Lance T Hall, Benjamin Titz, Nishanta Baidya, et al.
Investigational New Drugs
|
October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium report
Susan M Chang, John G Kuhn, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 2008
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118)
Jonathan P S Knisely, Brian Berkey, Arnab Chakravarti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
Frank S Lieberman, Meihua Wang, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2015
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513
David G Brachman, Stephanie L Pugh, Lynn S Ashby, et al.
Investigational New Drugs
|
August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs
Susan M Chang, John Kuhn, Patrick Wen, et al.
Neuro-Oncology
|
February 11, 2004
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas
S Clifford Schold, Demetrius M Kokkinakis, Susan M Chang, et al.
Neuro-Oncology
|
March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study
H Ian Robins, Susan M Chang, Michael D Prados, et al.
Physical Review Letters
|
December 24, 2019
Large Collective Lamb Shift of Two Distant Superconducting Artificial Atoms
P Y Wen, K-T Lin, A F Kockum, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 120) with videos related to
Sort By:
Page
of 12
Neuro-Oncology Advances
|
June 7, 2024
Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomas
Colin M Harari, Adam R Burr, Brett A Morris, et al.
Molecular Imaging and Biology
|
June 12, 2019
[<sup>124</sup>I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors
Lance T Hall, Benjamin Titz, Nishanta Baidya, et al.
Investigational New Drugs
|
October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium report
Susan M Chang, John G Kuhn, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 2008
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118)
Jonathan P S Knisely, Brian Berkey, Arnab Chakravarti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
Frank S Lieberman, Meihua Wang, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2015
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513
David G Brachman, Stephanie L Pugh, Lynn S Ashby, et al.
Investigational New Drugs
|
August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs
Susan M Chang, John Kuhn, Patrick Wen, et al.
Neuro-Oncology
|
February 11, 2004
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas
S Clifford Schold, Demetrius M Kokkinakis, Susan M Chang, et al.
Neuro-Oncology
|
March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study
H Ian Robins, Susan M Chang, Michael D Prados, et al.
Physical Review Letters
|
December 24, 2019
Large Collective Lamb Shift of Two Distant Superconducting Artificial Atoms
P Y Wen, K-T Lin, A F Kockum, et al.
Page
of 12